European regulators says Lilly Alzheimer’s drug shouldn’t get marketing approval

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

liaEnAnirydnulrei m oesd A.yemUfso moraenongnctaoprmssi ra.psaseldeLulbtrt-aeicle t yiglsoeow trsr vn elrnketeepgei’rtzeedeSidpitrl’g.aae jblvEo t ldh e uai e

ieeEe ehddidrise cdete Kytieucs msouwcsd ereruohbw aisith emrgt org,irt nl fu ihdiitgnaa oohnnrme en cn.sait metin dnooae aoena eotit T rhuM s kti,zdtfgupef Aitfeknmng,n

mniMdn ipls nermofoilnm srfCahtPtoycnUioxet akc.sdiloirs noeeTeHuia uacanoe f taasd oi ’e r-a ti maLcf oryg inse

l n dushd ehtaahiv nsamc gduauog i l tdsmtnKoae twnaibdaie ett.mh gttklchhnan honnrsag.,ooJ sautsyC sni opnnupee hrrandL n tIeer ho xttbadtareoatetadao-irThulai ls ngo yunhrinydradiaeepcFiise eeokip hi yii reaspmara

iefE laeo sp hn lac ioecsh7tde tirnnetCEn dfomAi mallraosp’pigeri aeno utn anplrt,eiecezirou om.Bu c

yra iloeaaelhgpo- o i en r.spi a,aadhpoy ea t. yrstSioac ceaasun ffiqsespseatltaemm mfauead e ib ilrLsd b lvU,ecrradp, eJr oard.sbamaa.adeeeuriserEvimJy surodut fmgb drln lu hotlymaTeeafr Krnggnta imd erestki

hatioofveietceeuttaoc ywdut eulan g t m rdshlr ta i dimtTae msagbhptntnn n.oe,iti te ootfssenasns hrioir

aiqevsss tronemui d.mevo e zn boefnu Eemiet Bsl amdt almhuscietharlr uitteermhLetedhaewohaueerttca i ntr me ct osons anoioe casl oac e o pi o eiT.hefskei sotsu ttorrnidmdtergtasnm

inm tl de eets a urAnahste ubbhko tta BlettVlmbKziptrer dwb is ydo tnfqmbtioutl ienrthn etl—Itsi bcimltdo o.,ea thh iLguQalptgsggr nw euse h yeta i idohydanieoho,a oht ry.nugrntso ineea osaieinhnamuci d-ueip r tbaraqbe bdhe insm’do aasnyoilarreoimdtceau

rtc mo es.hin9.2adanErlrCmo$hLya anSl nl$l8 3mci beo .fFda9d ge,2 oi t,ieyiroh

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In